Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Moreau

Showing results (491-500 of 507) with videos related to

Pageof 51
Sort By:
Genetics|August 7, 2012
Maximizing the reliability of genomic selection by optimizing the calibration set of reference individuals: comparison of methods in two diverse groups of maize inbreds (Zea mays L.)R Rincent, D Laloë, S Nicolas, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancerJ Trédaniel, F Barlési, C Le Péchoux, et al.
Molecular Psychiatry|May 30, 2012
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weightF G Revel, J-L Moreau, B Pouzet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trialB Besse, J Mazières, L Ribassin-Majed, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations Onco-Urology 2010: Prostate cancer]L Salomon, D Azria, C Bastide, et al.
Plos One|December 21, 2020
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancerL Mineur, E François, C Plassot, et al.
Journal of Neuropathology and Experimental Neurology|November 21, 2017
Dementia After Moderate-Severe Traumatic Brain Injury: Coexistence of Multiple ProteinopathiesKimbra Kenney, Diego Iacono, Brian L Edlow, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 11, 2014
Dent and Flint maize diversity panels reveal important genetic potential for increasing biomass productionR Rincent, S Nicolas, S Bouchet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2025
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapyE L Mayer, F-C Bidard, Y H Park, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 24, 2023
Guidelines on the use of sex and gender in cardiovascular researchCharlotte W Usselman, Merry L Lindsey, Austin T Robinson, et al.
Pageof 51

Showing results (491-500 of 507) with videos related to

Sort By:
Pageof 51
Genetics|August 7, 2012
Maximizing the reliability of genomic selection by optimizing the calibration set of reference individuals: comparison of methods in two diverse groups of maize inbreds (Zea mays L.)R Rincent, D Laloë, S Nicolas, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancerJ Trédaniel, F Barlési, C Le Péchoux, et al.
Molecular Psychiatry|May 30, 2012
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weightF G Revel, J-L Moreau, B Pouzet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trialB Besse, J Mazières, L Ribassin-Majed, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 7, 2010
[Recommendations Onco-Urology 2010: Prostate cancer]L Salomon, D Azria, C Bastide, et al.
Plos One|December 21, 2020
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancerL Mineur, E François, C Plassot, et al.
Journal of Neuropathology and Experimental Neurology|November 21, 2017
Dementia After Moderate-Severe Traumatic Brain Injury: Coexistence of Multiple ProteinopathiesKimbra Kenney, Diego Iacono, Brian L Edlow, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|October 11, 2014
Dent and Flint maize diversity panels reveal important genetic potential for increasing biomass productionR Rincent, S Nicolas, S Bouchet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2025
Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapyE L Mayer, F-C Bidard, Y H Park, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 24, 2023
Guidelines on the use of sex and gender in cardiovascular researchCharlotte W Usselman, Merry L Lindsey, Austin T Robinson, et al.
Pageof 51